lobbying_filings_raw: d825b8cf-4fed-42a9-9ad0-648b0183f837
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence | income_amount | expense_amount |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| d825b8cf-4fed-42a9-9ad0-648b0183f837 | 1T | 400918672 | PENN AVENUE PARTNERS | 196187 | PURDUE PHARMA L.P. | 2019 | first_quarter | 2019-01-16T17:34:48.747000-05:00 | 0 | 0 | 1 | {"url": "https://lda.senate.gov/api/v1/filings/d825b8cf-4fed-42a9-9ad0-648b0183f837/", "filing_uuid": "d825b8cf-4fed-42a9-9ad0-648b0183f837", "filing_type": "1T", "filing_type_display": "1st Quarter - Termination", "filing_year": 2019, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/d825b8cf-4fed-42a9-9ad0-648b0183f837/print/", "filing_document_content_type": "text/html", "income": "20000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Timothy F. Hannegan", "dt_posted": "2019-01-16T17:34:48.747000-05:00", "termination_date": "2019-01-03", "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "101 Constitution Avenue, NW", "registrant_address_2": "Suite L110", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20001", "registrant": {"id": 400918672, "url": "https://lda.senate.gov/api/v1/registrants/400918672/", "house_registrant_id": 42026, "name": "PENN AVENUE PARTNERS", "description": "â\u20ac\u2039Government Affairs.", "address_1": "701 Pennsylvania Avenue, NW", "address_2": "Suite 230", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20004", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "BETH ANNE COLE", "contact_telephone": "+1 202-256-5643", "dt_updated": "2026-01-27T13:57:41.474980-05:00"}, "client": {"id": 196187, "url": "https://lda.senate.gov/api/v1/clients/196187/", "client_id": 505, "name": "PURDUE PHARMA L.P.", "general_description": "Pharmaceutical company.", "client_government_entity": false, "client_self_select": null, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "CT", "ppb_state_display": "Connecticut", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2017-04-07"}, "lobbying_activities": [{"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Monitoring legislative and regulatory activities impacting the pharmaceutical industry.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 56689, "prefix": "mr", "prefix_display": "MR.", "first_name": "TIMOTHY", "nickname": null, "middle_name": "FARRELL", "last_name": "HANNEGAN", "suffix": null, "suffix_display": null}, "covered_position": "U.S. General Accounting Office", "new": false}], "government_entities": []}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 42026 | DC | CT | US | US | Pharmaceutical company. | 0 | 0 | 20000.0 |